Product
TVB-009
1 clinical trial
2 indications
Indication
OsteoporosisIndication
PostmenopausalClinical trial
A Randomized, Double-Blind, Multinational, Multicenter Study to Compare Efficacy, Safety, and Immunogenicity of TVB-009P and Denosumab (Prolia®) in Patients With Postmenopausal OsteoporosisStatus: Completed, Estimated PCD: 2022-12-31